1、 Product introduction
Chinese Name | English Name | Declaration Type | Department | Reportable Dosage Form | Declaration Progress | Strength | CAS |
达泊西汀 | (S)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine | 5+4 | Andrology | Tablet | Ready to declare | 30mg、60mg | 119356-77-3 |
【Indication】
Treatment of male premature ejaculation.
【Reportable Dosage Form &Strength】
Tablet :30mg、60mg
【Mechanism of Action】
A new type of GABA receptor agonist can block voltage dependent calcium channels and reduce the release of neurotransmitters.
【Development Progress】
Ready to declare
2、Domestic Declaration
Declaration Type | Reportable Dosage Form | Number of Declared Preparations | Number of Existing Preparation Enterprises |
5+4 | Tablet | 1 imported, 1 domestic | 1 imported |
![Brinzolamide 布林佐胺 CAS号:138890-62-7 Brinzolamide 布林佐胺 CAS号:138890-62-7]()
Guangzhou Tosun Pharmaceutical Ltd
FL 4-5,No.3, 2nd Kehui street, Science Park, Guangzhou High-tech Industrial Development Zone, Guangzhou, China. 510663
Tel: +86-20-66392521; Fax: +86-20-66392525